Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and pituitrin

fluorodeoxyglucose f18 has been researched along with pituitrin in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asa, SL; Cloughesy, TF; Green, RM; Heaney, AP; Kelly, DF; Kim, SSR; Li, JY; Mao, Q; Mareninov, S; McKeever, P; Movassaghi, M; Newell, KL; Qian, J; Rodriguez, FJ; Welsh, CT; Xiong, Z; Yong, WH; Zhang, D1

Other Studies

1 other study(ies) available for fluorodeoxyglucose f18 and pituitrin

ArticleYear
Somatostatin Receptor Ligand Therapy-A Potential Therapy for Neurocytoma.
    The Journal of clinical endocrinology and metabolism, 2019, 06-01, Volume: 104, Issue:6

    Topics: Adolescent; Brain Neoplasms; Cavernous Sinus; Fluorodeoxyglucose F18; Humans; Male; Neurocytoma; Peptides, Cyclic; Receptors, Somatostatin; Sella Turcica; Somatostatin; Vasopressins

2019